Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
81,374,906
-
Share change
-
+6,795,225
-
Total reported value
-
$4,843,899,307
-
Put/Call ratio
-
4.2%
-
Price per share
-
$59.54
-
Number of holders
-
378
-
Value change
-
+$408,515,363
-
Number of buys
-
191
-
Number of sells
-
165
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2023
As of 30 Jun 2023,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
378 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,374,906 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, NUANCE INVESTMENTS, LLC, STATE STREET CORP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, Champlain Investment Partners, LLC, and GW&K Investment Management, LLC.
This page lists
378
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.